Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Mouvements anormaux.

Burkhard P, Benninger D, Du Pasquier R, Kleinschmidt A.

Rev Med Suisse. 2018 Apr 25;14(604):867-868. French. No abstract available.

PMID:
29701430
2.

Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report.

Roemer S, Bissig A, Rocca A, Du Pasquier R, Guex-Crosier Y.

Klin Monbl Augenheilkd. 2018 Apr;235(4):476-477. doi: 10.1055/s-0043-124756. Epub 2018 Feb 16. No abstract available.

PMID:
29452449
3.

[Neurology].

Chopard I, Benninger D, Demonet JF, Du Pasquier R, Hirt L, Kuntzer T, Michel P, Nater B, Novy J, Rossetti A, Rouaud O, Ryvlin P, Schluep M, Theaudin M.

Rev Med Suisse. 2018 Jan 10;14(588-589):58-61. French.

PMID:
29337452
4.

Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.

Perrotta G, Bonnier G, Meskaldji DE, Romascano D, Aydarkhanov R, Daducci A, Simioni S, Cavassini M, Metral M, Lazeyras F, Meuli R, Krueger G, Du Pasquier RA, Granziera C.

Ann Clin Transl Neurol. 2017 Nov 7;4(12):915-920. doi: 10.1002/acn3.493. eCollection 2017 Dec.

5.

Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.

Mathias A, Perriot S, Canales M, Blatti C, Gaubicher C, Schluep M, Engelhardt B, Du Pasquier R.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 11;4(6):e401. doi: 10.1212/NXI.0000000000000401. eCollection 2017 Nov.

6.

The Combined Quantification and Interpretation of Multiple Quantitative Magnetic Resonance Imaging Metrics Enlightens Longitudinal Changes Compatible with Brain Repair in Relapsing-Remitting Multiple Sclerosis Patients.

Bonnier G, Maréchal B, Fartaria MJ, Falkowskiy P, Marques JP, Simioni S, Schluep M, Du Pasquier R, Thiran JP, Krueger G, Granziera C.

Front Neurol. 2017 Sep 27;8:506. doi: 10.3389/fneur.2017.00506. eCollection 2017.

7.

The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.

Merienne N, Vachey G, de Longprez L, Meunier C, Zimmer V, Perriard G, Canales M, Mathias A, Herrgott L, Beltraminelli T, Maulet A, Dequesne T, Pythoud C, Rey M, Pellerin L, Brouillet E, Perrier AL, du Pasquier R, Déglon N.

Cell Rep. 2017 Sep 19;20(12):2980-2991. doi: 10.1016/j.celrep.2017.08.075.

8.

Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis.

Rolf L, Muris AH, Mathias A, Du Pasquier R, Koneczny I, Disanto G, Kuhle J, Ramagopalan S, Damoiseaux J, Smolders J, Hupperts R.

Mult Scler. 2017 Jul 1:1352458517722646. doi: 10.1177/1352458517722646. [Epub ahead of print]

PMID:
28731372
9.

Organisation de la prise en charge des accidents vasculaires cérébraux en Suisse romande.

Carrera E, Hirt L, Sztajzel R, Michel P, Kleinschmidt A, Du Pasquier R.

Rev Med Suisse. 2017 Apr 26;13(560):883-884. French. No abstract available.

PMID:
28727353
10.

[Evaluation of an outpatient multidisciplinary Neuro-HIV clinic by the patients and referring doctors].

Vallotton K, Métral M, Chocron O, Meuli R, Alves D, Du Pasquier R, Cavassini M.

Rev Med Suisse. 2017 Apr 12;13(558):782-786. French.

PMID:
28727326
11.

[Neurology].

Maulucci F, Benninger D, Démonet JF, Du Pasquier RA, Hirt L, Hottinger A, Kuntzer T, Michel P, Nater B, Novy J, Rossetti AO, Schluep M, Vingerhoets FJG.

Rev Med Suisse. 2017 Jan 11;13(544-545):79-83. Review. French.

PMID:
28703543
12.

An unusual case of miliary PML-IRIS in an HIV+ patient.

Cuendet D, Sarro R, Merz L, Jiménez MC, Maeder P, Du Pasquier R, Tsouni P.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 14;4(4):e370. doi: 10.1212/NXI.0000000000000370. eCollection 2017 Jul. No abstract available.

13.

The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.

Kamal S, Locatelli I, Wandeler G, Sehhat A, Bugnon O, Metral M, Du Pasquier R, Gutbrod K, Cavassini M, Schneider MP; and the Swiss HIV Cohort Study.

Open Forum Infect Dis. 2017 Apr 6;4(2):ofx070. doi: 10.1093/ofid/ofx070. eCollection 2017 Spring.

14.

Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: An intriguing coincidence.

Bacchetta F, Mathias A, Schluep M, Du Pasquier R.

Mult Scler. 2017 Feb;23(2):300-303. doi: 10.1177/1352458516670734.

PMID:
28165319
15.

EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.

Clottu AS, Mathias A, Sailer AW, Schluep M, Seebach JD, Du Pasquier R, Pot C.

Cell Rep. 2017 Jan 3;18(1):213-224. doi: 10.1016/j.celrep.2016.12.006.

16.

Clinical Reasoning: An 82-year-old woman with dissociated aphasia followed by amnesia.

Eskioglou E, Du Pasquier RA, Rossetti AO, Sokolov AA.

Neurology. 2016 Aug 30;87(9):e91-6. doi: 10.1212/WNL.0000000000003047. No abstract available.

PMID:
27572435
17.

Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy risk.

Marignier R, Durand-Dubief F, du Pasquier R, Vukusic S.

Ann Neurol. 2016 Nov;80(5):791. doi: 10.1002/ana.24768. Epub 2016 Sep 15. No abstract available.

PMID:
27554031
18.

Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.

Mathias A, Perriard G, Canales M, Soneson C, Delorenzi M, Schluep M, Du Pasquier RA.

Mult Scler. 2017 May;23(6):802-809. doi: 10.1177/1352458516664210. Epub 2016 Aug 8.

PMID:
27503907
19.

[Paraneoplastic neurological syndromes: an update].

Zekeridou A, Ferfoglia RI, Du Pasquier R, Lalive PH.

Rev Med Suisse. 2016 Apr 27;12(516):832-4, 836-9. French.

PMID:
27281941
20.

Neuro-oncologie: la quintessence de la multidisciplinarité.

Hottinger AF, Kleinschmidt A, Du Pasquier R.

Rev Med Suisse. 2016 Apr 27;12(516):819. French. No abstract available.

PMID:
27281938
21.

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.

Disanto G, Benkert P, Lorscheider J, Mueller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue EW, Sprenger T, Stippich C, Derfuss T, Louvion JF, Kamm CP, Mattle HP, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive PH, Yaldizli Ö, Gobbi C, Kappos L, Kuhle J; SMSC Scientific Board.

PLoS One. 2016 Mar 31;11(3):e0152347. doi: 10.1371/journal.pone.0152347. eCollection 2016.

22.

Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.

Spatola M, Du Pasquier R, Schluep M, Regeniter A.

Neurology. 2016 May 10;86(19):1780-4. doi: 10.1212/WNL.0000000000002558. Epub 2016 Mar 16.

PMID:
26984947
23.

[Neurology].

Sokolov AA, Rossetti AO, Michel P, Benninger D, Nater B, Wider C, Hirt L, Kuntzer T, Démonet JF, Du Pasquier RA, Vingerhoets F.

Rev Med Suisse. 2016 Jan 13;12(500):62, 64-6. French.

PMID:
26946707
24.

The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.

Mathias A, Perriard G, Canales M, Vuilleumier F, Perrotta G, Schluep M, Du Pasquier R.

Neurol Neuroimmunol Neuroinflamm. 2016 Feb 10;3(2):e209. doi: 10.1212/NXI.0000000000000209. eCollection 2016 Apr.

25.

A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.

Bonnier G, Kober T, Schluep M, Du Pasquier R, Krueger G, Meuli R, Granziera C, Roche A.

PLoS One. 2016 Feb 4;11(2):e0148631. doi: 10.1371/journal.pone.0148631. eCollection 2016.

26.

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.

Kuhle J, Barro C, Disanto G, Mathias A, Soneson C, Bonnier G, Yaldizli Ö, Regeniter A, Derfuss T, Canales M, Schluep M, Du Pasquier R, Krueger G, Granziera C.

Mult Scler. 2016 Oct;22(12):1550-1559. Epub 2016 Jan 11.

PMID:
26754800
27.

Automated detection of white matter and cortical lesions in early stages of multiple sclerosis.

Fartaria MJ, Bonnier G, Roche A, Kober T, Meuli R, Rotzinger D, Frackowiak R, Schluep M, Du Pasquier R, Thiran JP, Krueger G, Bach Cuadra M, Granziera C.

J Magn Reson Imaging. 2016 Jun;43(6):1445-54. doi: 10.1002/jmri.25095. Epub 2015 Nov 25.

PMID:
26606758
28.

Relapse in herpes simplex virus encephalitis: It's not just about the virus.

Bale JF Jr, Du Pasquier R.

Neurology. 2015 Nov 17;85(20):1730-1. doi: 10.1212/WNL.0000000000002132. Epub 2015 Oct 21. No abstract available.

PMID:
26491087
29.

PML risk stratification using anti-JCV antibody index and L-selectin.

Schwab N, Schneider-Hohendorf T, Pignolet B, Spadaro M, Görlich D, Meinl I, Windhagen S, Tackenberg B, Breuer J, Cantó E, Kümpfel T, Hohlfeld R, Siffrin V, Luessi F, Posevitz-Fejfár A, Montalban X, Meuth SG, Zipp F, Gold R, Du Pasquier RA, Kleinschnitz C, Jacobi A, Comabella M, Bertolotto A, Brassat D, Wiendl H.

Mult Scler. 2016 Jul;22(8):1048-60. doi: 10.1177/1352458515607651. Epub 2015 Oct 2.

PMID:
26432858
30.

Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.

Bonnier G, Roche A, Romascano D, Simioni S, Meskaldji DE, Rotzinger D, Lin YC, Menegaz G, Schluep M, Du Pasquier R, Sumpf TJ, Frahm J, Thiran JP, Krueger G, Granziera C.

Biomed Res Int. 2015;2015:569123. doi: 10.1155/2015/569123. Epub 2015 Jul 29.

31.

CSF lactate for accurate diagnosis of community-acquired bacterial meningitis.

Giulieri S, Chapuis-Taillard C, Jaton K, Cometta A, Chuard C, Hugli O, Du Pasquier R, Bille J, Meylan P, Manuel O, Marchetti O.

Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2049-55. doi: 10.1007/s10096-015-2450-6. Epub 2015 Aug 19.

PMID:
26282789
32.

A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up.

Derfuss T, Curtin F, Guebelin C, Bridel C, Rasenack M, Matthey A, Du Pasquier R, Schluep M, Desmeules J, Lang AB, Perron H, Faucard R, Porchet H, Hartung HP, Kappos L, Lalive PH.

J Neuroimmunol. 2015 Aug 15;285:68-70. doi: 10.1016/j.jneuroim.2015.05.019. Epub 2015 May 20.

PMID:
26198921
33.

Status epilepticus of inflammatory etiology: a cohort study.

Spatola M, Novy J, Du Pasquier R, Dalmau J, Rossetti AO.

Neurology. 2015 Aug 4;85(5):464-70. doi: 10.1212/WNL.0000000000001717. Epub 2015 Jun 19.

34.

Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.

Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, Schaeren-Wiemers N, Du Pasquier RA.

J Neuroinflammation. 2015 Jun 16;12:119. doi: 10.1186/s12974-015-0335-3.

35.

Management of Fulminant Multiple Sclerosis With Rituximab: A Case Report.

Parfenov V, Du Pasquier R, Schluep M.

Neurologist. 2015 Jun;19(6):155-7. doi: 10.1097/NRL.0000000000000030.

PMID:
26075469
36.

[Deep brain stimulation and "translational revolution": the central role of clinicians].

Vingerhoets FJ, Burkhard PR, Du Pasquier R, Pollak P.

Rev Med Suisse. 2015 Apr 29;11(472):955-6. French. No abstract available.

PMID:
26062219
37.

Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.

Kurmann R, Weisstanner C, Kardas P, Hirsch HH, Wiest R, Lämmle B, Furrer H, Du Pasquier R, Bassetti CL, Sturzenegger M, Krestel H.

J Neurovirol. 2015 Dec;21(6):694-701. doi: 10.1007/s13365-015-0340-4. Epub 2015 Apr 28.

PMID:
25916731
38.

[Giant cell arteritis: guidelines of the University Hospital of Lausanne].

Tsetsou S, Michel P, Ribi C, Hirt L, Kawasaki A, Hugli O, De Leval L, Bart PA, Waeber G, Meuli R, Raffoul W, So A, Du Pasquier R; University Hospital of Lausanne.

Rev Med Suisse. 2015 Feb 11;11(461):411-7. French.

PMID:
25895220
39.

[Multiple sclerosis: when to think of it? How to proceed?].

Du Pasquier R.

Rev Med Suisse. 2015 Jan 28;11(459):282-3. French. No abstract available.

PMID:
25845178
40.

[News in neurology 2014].

Tsetsou S, Rossetti AO, Michel P, Hirt L, Wider C, Benninger D, Kuntzer T, Nater B, Démonet JF, Schluep M, Du Pasquier RA, Vingerhoets F.

Rev Med Suisse. 2015 Jan 14;11(456-457):91-6. French.

PMID:
25799659
41.

Environmental factors in multiple sclerosis.

Pantazou V, Schluep M, Du Pasquier R.

Presse Med. 2015 Apr;44(4 Pt 2):e113-20. doi: 10.1016/j.lpm.2015.01.001. Epub 2015 Mar 2.

PMID:
25744944
42.

Acute Lyme Neuroborreliosis With Transient Hemiparesis and Aphasia.

Sokolov AA, Lienhard R, Du Pasquier R, Erard V.

Ann Emerg Med. 2015 Jul;66(1):60-4. doi: 10.1016/j.annemergmed.2015.01.011. Epub 2015 Feb 26.

PMID:
25728308
43.

Posterior spinal cord infarctions due to neurosyphilis.

Bill O, Du Pasquier RA, Michel P.

Neurol Clin Pract. 2014 Dec;4(6):538-540. doi: 10.1212/CPJ.0000000000000053. No abstract available.

44.

A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.

Derfuss T, Curtin F, Guebelin C, Bridel C, Rasenack M, Matthey A, Du Pasquier R, Schluep M, Desmeules J, Lang AB, Perron H, Faucard R, Porchet H, Hartung HP, Kappos L, Lalive PH.

Mult Scler. 2015 Jun;21(7):885-93. doi: 10.1177/1352458514554052. Epub 2014 Nov 12.

PMID:
25392325
45.

Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.

Bonnier G, Roche A, Romascano D, Simioni S, Meskaldji D, Rotzinger D, Lin YC, Menegaz G, Schluep M, Du Pasquier R, Sumpf TJ, Frahm J, Thiran JP, Krueger G, Granziera C.

Ann Clin Transl Neurol. 2014 Jun;1(6):423-32. doi: 10.1002/acn3.68. Epub 2014 Jun 3.

46.

Immune system's role in viral encephalitis.

Spatola M, Du Pasquier RA.

Rev Neurol (Paris). 2014 Oct;170(10):577-83. doi: 10.1016/j.neurol.2014.07.005. Epub 2014 Sep 2.

PMID:
25189678
47.

Minimal supportive treatment in natalizumab-related PML in a MS patient.

Lalive PH, Bridel C, Ferfoglia RI, Kaiser L, Du Pasquier R, Barkhof F, Haller S.

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):354-5. doi: 10.1136/jnnp-2014-308154. Epub 2014 Jun 23. No abstract available.

PMID:
24957322
48.

MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.

Simioni S, Amarù F, Bonnier G, Kober T, Rotzinger D, Du Pasquier R, Schluep M, Meuli R, Sbarbati A, Thiran JP, Krueger G, Granziera C.

J Neurol. 2014 Aug;261(8):1606-13. doi: 10.1007/s00415-014-7398-4. Epub 2014 Jun 10.

PMID:
24912471
49.

[Intracerebral HIV replication despite an efficient antiretroviral treatment: clinical impact and management].

Schibler M, Calmy A, Cavassini M, Du Pasquier R.

Rev Med Suisse. 2014 Apr 23;10(427):908, 910-2. French.

PMID:
24843987
50.

Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.

Du Pasquier RA, Pinschewer DD, Merkler D.

CNS Drugs. 2014 Jun;28(6):535-58. doi: 10.1007/s40263-014-0160-8. Review.

Supplemental Content

Loading ...
Support Center